Prospects for adenovirus-mediated gene therapy of inherited diseases of the myocardium

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 422-430

  Bowles, Neil E ^a   Wang, Qing ^a   Towbin, Jeffrey A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenovirus; Cardiomyopathy; Long QT

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; GENE THERAPY; HEART DILATATION; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; PRIORITY JOURNAL; REVIEW; VIRUS GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; CARDIOMYOPATHIES; GENE THERAPY; GENETIC VECTORS; HUMANS; RESEARCH;

EID: 0030730116     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00162-4     Document Type: Review

References (95)

1. Muntoni F, Cau M, Ganau Aet al. Brief report: Deletion of the dystrophin muscle-specific promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 329:1993;921-925.
2. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nature Genet. 12:1996;385-389.
3. Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 95:1997;2434-2440.
4. Tanigawa G, Jarcho JA, Kass Aet al. A molecular basis for familial hypertrophic cardiomyopathy: An α/β cardiac myosin heavy chain hybrid gene. Cell. 62:1990;991-998.
5. Geisterfer-Lowrance AAT, Kass A, Tanigawa Get al. A molecular basis for familial hypertrophic cardiomyopathy: A β-cardiac myosin heavy chain missense mutation. Cell. 62:1990;999-1006.
6. Vosberg H-P Myosin mutations in hypertrophic cardiomyopathy and functional implications. Herz. 19:1994;75-83.
7. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 80:1995;795-803.
8. Wang Q, Shen J, Splawski Iet al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 80:1995;805-811.
9. Wang Q, Curran ME, Splawski Iet al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genet. 12:1996;17-23.
10. Bowles NE, Woo SLC Gene therapy for metabolic disorders. Adv Drug Deliv Rev. 17:1995;293-302.
11. Crystal RG The gene as a drug. Nature Med. 1:1995;15-17.
12. Nabel EG Gene transfer for vascular diseases. Atherosclerosis. 1188:1995;S51-S56.
13. Lafont A, Guerot C, Lemarchand P Prospects for gene therapy in cardiovascular disease. Eur Heart J. 17:1996;1312-1317.
14. Wilson JM Adenoviruses as gene-delivery vehicles. New Engl J Med. 334:1996;1185-1187.
15. Boucher RC, Knowles MR, Johnson LGet al. Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I clinical trial in the nasal cavity. Hum Gene Ther. 5:1994;615-639.
16. Wilson JM, Engelhardt JF, Grossman M, Simon RH, Yang Y Gene therapy for cystic fibrosis lung disease using E1 deleted adenoviruses: A phase I trial. Hum Gene Ther. 5:1994;501-519.
17. Horwitz MS. Adenoviridae and their replication. In: Fields BN, Knipe DM, Chanock RM, et al., eds. Virology, 2nd ed. New York: Raven Press, 1990:1679-1721.
18. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecular Biology. Clifton, NJ: Humana Press, 1991:109-128.
19. Huard J, Lochmuller H, Ascadi G, Jani A, Massie B, Karpati G The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:1995;107-115.
20. Rosahl T, Doerfler W Predominant association of adenovirus type 12 DNA with human chromosome 1 early in productive infection. Virology. 162:1988;494-497.
21. Kass-Eisler A, Falck-Pederson E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:1994;395-402.
22. Gilgenkrantz H, Duboc D, Juillard Vet al. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Human Gene Ther. 6:1995;1265-1274.
23. Wang J, Ma Y, Knechtle SJ Adenovirus-mediated gene transfer into rat cardiac allografts: Comparison of direct injection and perfusion. Transplantation. 61:1996;1726-1729.
24. Lee J, Laks H, Drinkwater DCet al. Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J Thoracic Cardiovascular Surg. 111:1996;246-252.
25. Magovern CJ, Mack CA, Zhang Jet al. Direct in vivo gene transfer to canine myocardium using a replication-defective adenovirus vector. Ann Thoracic Surg. 62:1996;425-433.
26. French BA, Mazur W, Geske RS, Bolli R Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation. 90:1994;2414-2424.
27. Barr E, Carroll J, Kalynych AMet al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1:1994;51-58.
28. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 90:1992;626-630.
29. Yang Y, Li Q, Ertl HC, Wilson JM Cellular and humoral Immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 69:1995;2004-2015.
30. Fang B, Wang H, Gordon Get al. Lack of persistence of E1-recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Therapy. 3:1996;212-222.
31. Engelhardt JF, Litzky L, Wilson JM Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther. 5:1994;1217-1229.
32. - adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther. 2:1995;256-262.
33. Gao G-P, Yang Y, Wilson JM Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol. 70:1996;8934-8943.
34. Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virol. 217:1996;11-22.
35. Haecker SE, Stedman HH, Balice-Gordon RJet al. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther. 7:1996;1907-1914.
36. Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT A new adenoviral vector replacement of all viral coding sequences with 28kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci USA. 93:1996;5731-5736.
37. Barr D, Tubb J, Ferguson Det al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:1995;151-155.
38. Zepeda M, Wilson JM Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors. Gene Ther. 3:1996;973-979.
39. Fang B, Eisensmith RC, Wang Het al. Gene Therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther. 6:1995;1039-1044.
40. Kay MA, Holterman AX, Meuse Let al. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet. 11:1995;191-197.
41. Lee KJ, Ross RS, Rockman HAet al. Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. J Biol Chem. 267:1992;15875-15885.
42. Rothmann T, Katus HA, Hartong R, Perricaudet M, Franz W-M Heart muscle-specific gene expression using replication defective recombinant adenovirus. Gene Ther. 3:1996;919-926.
43. Wang Y, O'Malley BW Jr., Tsai SY, O'Malley BW A regulatory system for use in gene transfer. Proc Natl Acad Sci USA. 91:1994;8180-8184.
44. Baron U, Freundlieb S, Gossen M, Bujard H Co-regulation of two gene activities by tetracycline via a bi-directional promoter. Nucl Acid Res. 23:1995;3605-3606.
45. Dhawan J, Rando TA, Elson SL, Bujard H, Blau HM Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Som Cell Mol Genet. 21:1995;233-240.
46. Manolio TA, Baughman KL, Rodeheffer Ret al. Prevalence and etiology of idiopathic dilated cardiomyopathy (Summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol. 69:1992;1458-1466.
47. Dec GW Fuster V. Idiopathic dilated cardiomyopathy. New Engl J Med. 331:1994;1564-1575.
48. Kasper EK, Agena WRP, Hutchins GM, Deckers JW, Hare JM, Baughman KL The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol. 23:1994;586-590.
49. Kelly DP, Strauss AW Inherited cardiomyopathies. New Engl J Med. 330:1994;930-932.
50. Michels VV, Moll PP, Miller FAet al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. New Engl J Med. 326:1992;77-82.
51. Keeling PJ, Gang Y, Smith G, et al. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 1995;417-421.
52. Towbin JA, Hejtmancik JF, Brink Pet al. X-linked dilated cardiomyopathy: Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 87:1993;1854-1865.
53. Durand JB, Bachinski LL, Bieling LCet al. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation. 92:1995;3387-3389.
54. Krajinovic M, Pinamonti B, Sinagra Get al. Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet. 57:1995;846-852.
55. Bowles KR, Gajarski R, Porter Pet al. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest. 98:1996;1355-1360.
56. Kass S, MacRae C, Graber HLet al. A genetic defect that causes conduction system disease and dilated cardiomyopathy maps to 1p1-1q1. Nature Genet. 7:1994;546-551.
57. Olson TM, Keating MT Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest. 97:1996;528-532.
58. Hoffman EP, Brown RH, Kunkel LM Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
59. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 337:1989;176-179.
60. England SB, Nicholson LV, Johnson MAet al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 343:1990;180-182.
61. Ragot T, Vincent N, Chafey Pet al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature. 361:1993;647-650.
62. Vincent N, Ragot T, Gilgenkrantz Het al. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5:1993;130-134.
63. Alameddine HS, Quantin B, Cartaud A, Dehaupas M, Mandel JL, Fardeau M Expression of a recombinant dystrophin in mdx mice using adenovirus vector. Neuromusc Disord. 4:1994;193-203.
64. Clemens PR, Kochanek S, Sunada Yet al. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3:1996;965-972.
65. Eschengen T, Diedrich M, Kluge SHet al. Bovine hereditary cardiomyopathy: An animal model of human dilated cardiomyopathy. J Mol Cell Cardiol. 27:1995;357-370.
66. Thierfelder L, Watkins H, MacRae Cet al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell. 77:1994;701-712.
67. Bonne G, Carrier L, Bercovici Jet al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet. 11:1995;438-440.
68. Watkins H, Conner D, Thierfelder Let al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet. 11:1995;434-437.
69. Poetter K, Jiang H, Hassanzadeh Set al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genet. 13:1996;63-69.
70. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 90:1994;2731-2742.
71. Watkins H, McKenna WJ, Thierfelder Let al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. New Engl J Med. 332:1995;1058-1064.
72. Geisterfer-Lowrance AA, Christe M, Conner DAet al. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:1996;731-734.
73. Marian AJ, Yu QT, Mann DL, Graham FL, Roberts R Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res. 77:1995;98-106.
74. Yu M, Poeschla E, Wong-Staal F Progress towards gene therapy for HIV infection. Gene Ther. 1:1994;13-26.
75. Bashkin JK, Sampath U, Frolova E Ribozyme mimics as catalytic antisense reagents. Appl Biochem Biotech. 54:1995;43-56.
76. Lieber A, Kay MA Adenovirus-mediated expression of ribozymes in mice. J Virol. 70:1996;3153-3158.
77. Feng M, Cabrera G, Deshane J, Scanlon KJ, Curiel DT Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res. 55:1995;2024-2028.
78. Keating MT, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppart M Linkage of a cardiac arrhythmia, the long QT syndrome and the Harvey ras-1 gene. Science. 252:1991;704-706.
79. Towbin JA, Li H, Taggart RTet al. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: Analysis of 23 families. Circulation. 90:1994;2635-2644.
80. Jiang C, Atkinson D, Towbin JAet al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nature Genet. 8:1994;141-147.
81. Schott JJ, Charpentier F, Peltier Set al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet. 57:1995;1114-1122.
82. + channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation. 92:1995;3381-3386.
83. Compton SJ, Lux RL, Ramsey MRet al. Genetically defined therapy of the inherited long-Qt syndrome. Correction of abnormal repolarization by potassium. Circulation. 94:1996;1018-1022.
84. Nuss HB, Johns DC, Kaab Set al. Reversal of potassium channel deficiency in cells from failing hearts by adenoviral gene transfer: A prototype for gene therapy for disorders of cardiac excitability. Gene Ther. 3:1996;900-912.
85. Wolff MR, de Tombe PP, Harasawa Yet al. Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. Circ Res. 70:1992;516-529.
86. Williams RE, Kass DA, Kawagoe Yet al. Endomyocardial gene expression during development of pacing tachycardia-induced heart failure in the dog. Circ Res. 75:1994;615-623.
87. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC Detection of Coxsackie-B-Virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1:1986;1120-1122.
88. Kandolf R, Ameis D, Kirschner P, Canu A, Hofschnieder PH In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: An approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA. 84:1987;6272-6276.
89. Bowles NE, Rose ML, Taylor Pet al. End-stage dilated cardiomyopathy: Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation. 80:1989;1128-1136.
90. Schonian U, Crombach M, Maser S, Maisch B Cytomegalovirus-associated heart muscle disease. Eur Heart J. 16(Suppl O):1995;46-49.
91. Martin AB, Webber S, Fricker FJet al. Acute myocarditis: Rapid diagnosis by PCR in children. Circulation. 90:1994;330-339.
92. Griffin LD, Kearney D, Ni Jet al. Analysis of formalin-fixed and frozen myocardial autopsy samples for viral genome in childhood myocarditis and dilated cardiomyopathy with endocardial fibroelastosis using polymerase chain reaction (PCR). Cardiovascular Pathol. 4:1995;3-11.
93. Bergelson JM, Cunningham JA, Droguett Get al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
94. Prince GA, Porter DD, Jenson AB, Horswood RL, Chanock RM, Ginsberg HS Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J Virol. 67:1993;101-111.
95. Cunningham L, Bowles NE, Lane RJ, Dubowitz V, Archard LC Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol. 71:1990;1399-1402.